Provided by Tiger Trade Technology Pte. Ltd.

Jupiter Neurosciences

6.20
+1.0319.92%
Post-market: 6.12-0.0800-1.29%19:59 EDT
Volume:52.41M
Turnover:445.04M
Market Cap:4.77M
PE:-0.33
High:11.20
Open:8.25
Low:5.50
Close:5.17
52wk High:137.96
52wk Low:4.56
Shares:770.10K
Float Shares:533.80K
Volume Ratio:1,111.30
T/O Rate:9817.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.7000
EPS(LYR):-18.7500
ROE:-1888.70%
ROA:-159.56%
PB:-13.05
PE(LYR):-0.33

Loading ...

Company Profile

Company Name:
Jupiter Neurosciences
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
- -
Office Location:
1001 North US Highway 1,Suite 504,Palm Beach Gardens,Jupiter,Florida,United States
Zip Code:
33477
Fax:
- -
Introduction:
Jupiter Neurosciences, Inc. was incorporated in Delaware in January 2016. The company is a clinical-stage R&D company focused on developing treatments for neuroinflammation using its proprietary resveratrol formulation, JOTROL. Its primary therapeutic target is Parkinson's disease, for which it plans to conduct a Phase IIa clinical trial, and it has launched a consumer-facing product line called Nugevia focused on longevity and wellness.

Directors

Name
Position
Christer Rosén
Chairman of the Board and Chief Executive Officer
Alison D. Silva
Chief Operating Officer and Director and President
Holger Weis
Independent Director
Nicholas H. Hemmerly
Independent Director

Shareholders

Name
Position
Christer Rosén
Chairman of the Board and Chief Executive Officer
Alison D. Silva
Chief Operating Officer and Director and President
Saleem Elmasri
Chief Financial Officer and Secretary
Alexander Rosén
Chief Administrative Officer
Marshall Hayward
Chief Scientific Officer